Drug Topics
NOVEMBER 14, 2024
Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.
STAT
NOVEMBER 12, 2024
Pfizer’s promising research on a treatment for a dangerous cancer-related condition is also helping prove out the value of wearables in clinical trials. In September, the pharma giant reported results showing that an experimental antibody could positively impact people with cachexia, a complication sometimes called “wasting syndrome” that can cause people with cancer to lose weight and make it harder for them to tolerate treatments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
NOVEMBER 11, 2024
Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.
The Checkup by Singlecare
NOVEMBER 11, 2024
Finding the right medication to manage a mental health condition is difficult, and it can take some trial and error to settle on an effective treatment plan. Two commonly prescribed medications for various mental health conditions are trazodone and Lexapro. As a brand-name prescription drug, Lexapro is FDA -approved to treat major depressive disorder and anxiety disorders.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 15, 2024
A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.
STAT
NOVEMBER 12, 2024
The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine. To Palinski, buprenorphine is a godsend.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmafile
NOVEMBER 13, 2024
Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.
Drug Topics
NOVEMBER 15, 2024
A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.
STAT
NOVEMBER 13, 2024
Sen. John Thune (R-S.D.), the newly elected Senate majority leader, is big on telehealth, rural hospitals, and increasing transparency for drug middlemen. As majority leader, Thune will be in charge of coordinating the entire Republican policy agenda, and it’s not clear how health care will fit into the mix. He represents a state that does not have much in the way of special interests in the health care industry beyond hospitals, doctors, and pharmacists.
The Checkup by Singlecare
NOVEMBER 15, 2024
No matter the time of year, there’s always a family get-together, wedding celebration, or festive party just waiting to sabotage your weight loss goals—with delicious treats and alcoholic beverages. If you’re taking Zepbound (tirzepatide), there’s an added layer to consider besides the extra calories: Is it safe to drink while taking this medication?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
NOVEMBER 12, 2024
Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) therapies after its drug candidate pimicotinib cleared a phase 3 trial.The German group said the CSF-1R inhibitor given as a once-daily, oral dose hit its primary endpoint in the MANEUVER study, achieving an objective response rate (ORR) at week 25 of 54% compared to 3.2% for a matched placebo in patients with TGCT, a rare disease affecting the joints and tendons.
Drug Topics
NOVEMBER 15, 2024
After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.
Fierce Healthcare
NOVEMBER 15, 2024
Though hospital performance has remained relatively stable, high labor costs continue to challenge hospitals’ bottom line, according to September figures from Kaufman Hall. | Labor expenses from providers accounted for 84% of medical groups’ total expenses. The median subsidy per employed physician was $304,312, rising above $300,000 for the first time.
Fierce Pharma
NOVEMBER 13, 2024
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in acquiring external products with the potential to launch in the near term. | As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in acquiring external products with the potential to launch in the near term, according to a new loss of exclusivity report from Leerink Partners.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The FDA Law Blog
NOVEMBER 10, 2024
By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.
Drug Topics
NOVEMBER 14, 2024
Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.
pharmaphorum
NOVEMBER 14, 2024
There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't left behind. Its solution is a licensing deal with Chinese biotech LaNova Medicines for LM-299, which consists of an anti-VEGF antibody joined to the functional parts of a pair of anti-PD-1 antibodies.
PharmaVoice
NOVEMBER 13, 2024
As the industry’s marketing dollars shift, companies are targeting potential patients in unique ways.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Guardian - Pharmaceutical Industry
NOVEMBER 9, 2024
As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition Occupational stress is a trigger for Rebecca Wilde, a 32-year-old tech worker in Buckinghamshire. Four years ago, work pressures combined with family issues affected her sleep, leading to a severe manic episode.
Drug Topics
NOVEMBER 9, 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
pharmaphorum
NOVEMBER 13, 2024
Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a treatment for relapsed and refractory multiple myeloma (RRMM).The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside Bristol-Myers Squibb/Celgene's Imnovid (pomalidomide) and dexamethasone (Isa-Pd) for relapsed RRMM.
Pharma Marketing Network
NOVEMBER 15, 2024
In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. PPC does just that. But how does it work, and how can you make the most of it in the competitive pharmaceutical industry?
OctariusRx
NOVEMBER 13, 2024
The 2024 version of the OctariusRx USP 800 assessment quiz is about to be released! With the enforcement of USP Chapter 800 beginning last year on November 1, 2023, facilities will be required to assess staff competency on an annual basis. Ongoing education and assessments of staff in the handling of hazardous medications is not only a regulatory requirement, but also a standard of good practice.
Drug Topics
NOVEMBER 11, 2024
Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.
PharmaVoice
NOVEMBER 14, 2024
While Martin Shkreli smirked his way through a public securities fraud investigation, Ron Tilles became interim CEO of Turing Pharmaceuticals, ready or not. Here’s his story.
Pharma Marketing Network
NOVEMBER 15, 2024
In the world of pharmaceutical marketing, social media marketing strategies are more than a trend; they’re a necessity. But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? The answer lies in a mix of proven strategies designed for this unique sector. Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influenc
pharmaphorum
NOVEMBER 12, 2024
Virtual wards (also known as hospital at home) allow patients to get the care they need at home safely and conveniently, rather than being in hospital. The NHS is increasingly introducing virtual wards to support people at the place they call home, including care homes. In today’s podcast, web editor Nicole Raleigh speaks with Dr Samuel Ewing, global head of pharma partnerships at Doccla, about the next generation of digital tools such as wearable medical devices, as well as remote patient monit
Drug Topics
NOVEMBER 12, 2024
Pharmacy law experts detailed the Drug Supply Chain Security Act, highlighting the role each entity within the supply chain plays in ensuring the safety and authenticity of US prescription drugs.
Fierce Healthcare
NOVEMBER 11, 2024
Meharry Medical College in Nashville, Tennessee, is collaborating with Oracle on a new project to advance healthcare access, innovation and education in Middle Tennessee and beyond. | The organizations plan to establish a joint research collaborative focused on precision medicine and health informatics, a health innovation hub and a community care and wellness center in Nashville.
Pharma Marketing Network
NOVEMBER 15, 2024
The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Digital advertising is no longer just a nice addition; it’s a must-have for every successful pharma marketing strategy. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Let’s explore some proven strategies that will help you master digital advertising and drive significant results.
pharmaphorum
NOVEMBER 12, 2024
AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026 as part of a drive to raise its revenues to $80 billion by the end of the decade.The programme – part of the pharma group's Ambition 2030 effort – will include the construction of a new R&D centre at Kendall Square in the heart of the biopharma hub in Cambridge, Massachusetts, and a biologics manufacturing facility in Maryland.
Drug Topics
NOVEMBER 11, 2024
Research has found that children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID.
Pharmacy Times
NOVEMBER 15, 2024
Panelists discuss how pharmacists can address remaining unmet needs and challenges in optimizing frontline therapy for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM), including areas such as managing complex drug interactions, improving medication adherence, mitigating treatment-related toxicities, streamlining transitions of care, and enhancing patient education and support throughout the treatment journey.
Expert insights. Personalized for you.
281 
Let's personalize your content